Blood markers may reveal hormone therapy success in breast cancer
NCT ID NCT01612871
First seen Apr 18, 2026 · Last updated May 22, 2026 · Updated 7 times
Summary
This study looked at 39 women with advanced breast cancer who were starting hormone therapy (tamoxifen or aromatase inhibitors). Researchers checked their blood for tiny molecules called microRNAs that might show whether the cancer is sensitive or resistant to the treatment. The goal was to see if these blood markers could help predict treatment response in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Val d'Aurelle - Paul Lamarque
Montpellier, 34298, France
-
Institut Claudius REGAUD Toulouse
Toulouse, 31052, France
Conditions
Explore the condition pages connected to this study.